Font Size: a A A
Keyword [relapsed/refractory diffuse large B-cell lymphoma]
Result: 1 - 10 | Page: 1 of 1
1. The Separation Of Specific Serum Protein Biomarker In Patients With Relapse/refractory Diffuse Large B Cell Lymphoma And The Study Of Its Clinical Value
2. Predictive Value Of Serum Amyloid A And Misfolded Transthyretin In Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
3. Clinical Characteristics And Prognosis Prediction Model For Patients With Relapsed/refractory Diffuse Large B-cell Lymphoma
4. The Clinical Observation Of The Modified BACOD Regimen Combined With Recombinant Mutated Human Tumor Necrosis Factor For Relapsed/refractory Diffuse Large B-cell Lymphoma
5. Analysis Of The Efficacy,Side Effects And Prognostic Factors Of DA-EPOCH±R Regimen And Modified ESHAP±R Regimen For Relapsed/Refractory Diffuse Large B-cell Lymphoma
6. CAR19-T Cells Secreting IL-21 And PD1-Fc For The Treatment Of Relapsed/refractory Diffuse Large B Cell Lymphoma
7. Clinical Efficacy And Safety Analysis Of Apatinib In The Treatment Of Relapsed And Refractory Diffuse Large B-cell Lymphoma
8. Safety And Efficacy Of Anti-PD-1/PD-l1 Antibodies In Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma:a Meta-Analysis
9. Study On The Mechanism Of Human-derived CD19 CAR-T Cell Therapy In Rescuing Relapsed/Refractory Diffuse Large B-cell Lymphoma Unresponsive To Mouse-derived CD19 CAR-T Cell Therapy
10. Study On TCM Syndromes Of CAR-T Therapy For Relapsed/refractory Diffuse Large B-cell Lymphoma And Analysis Of Related Factors Affecting Efficac
  <<First  <Prev  Next>  Last>>  Jump to